Who was studied, and how
Three numbers in the abstract
Where each one falls
Where it lands on the map
people with type 2 diabetes, in this paper
The trial randomly assignedassigned by chance
gemigliptin 50 mg qd + metformin 1000 to 2000 mg qd
baseline
Reported lower HbA1c level, no range given−2.06
randomisedThe trial randomly assignedassigned by chance
gemigliptin 50 mg qd
baseline
Reported lower HbA1c level, no range given−1.24
randomisedthe abstract, start to end
… level from baseline to week 24 were -2.06%, -1.24% and -1.47% in the combination, …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
HbA1c levelgemigliptin 50 mg qd + metformin 1000 to 2000 mg qd vs baseline
−2.06
HbA1c levelgemigliptin 50 mg qd vs baseline
−1.24
HbA1c levelmetformin 1000 to 2000 mg qd vs baseline
−1.47
MetforminDPP-4 inhibitorsGlycemic control
1 / 4